SCHEMBL462220

SCHEMBL462220

CC1CN(Cc2nnc(-c3cc(-c4cnc(Cl)c(NS(C)(=O)=O)c4)cc4[nH]ncc34)o2)C[C@H](C)O1

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 16/20 0.65
PIK3CG P48736 12/20 0.65
PIK3CA P42336 12/20 0.65
PIK3CB P42338 11/20 0.65
PIK3R2 O00459 1/20 0.65
PIK3R1 P27986 4/20 0.40
JAK2 O60674 2/20 0.38
JAK1 P23458 2/20 0.38
TYK2 P29597 2/20 0.38
JAK3 P52333 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL462221 1.00 PIK3CD (0.65) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL715647 1.00 PIK3CD (0.65) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL459118 0.90 PIK3CD (0.80) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL714987 0.90 PIK3CD (0.80) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL460697 0.88 PIK3CG (0.51) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL463595 0.87 PIK3CD (0.48) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL16667386 0.84 PIK3CD (0.51) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL10187719 0.83 PIK3CD (0.55) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL10187712 0.82 PIK3CD (0.53) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2
SCHEMBL458644 0.81 PIK3CD (0.68) PIK3CDPIK3CGPIK3CAPIK3CBPIK3R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2613781-A1 INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION GlaxoSmithKline Intellectual Property Development Limited (GB) 2013-07-17 EP disclosed
WO-2012032065-A1 INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION GLAXO GROUP LIMITED (GB) 2012-03-15 WO disclosed